Neurocrine Biosciences Inc (NBIX) Insider Trading

Total insider buys:
  • $39,032,821.44
Total insider sells:
  • $346,242,053.69
Most recent insider trade:
  • Aug. 15, 2024
Most active insider trader:
  • Kevin Charles Gorman
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 15, 2024Director14,250$146.69Sell$2,090,332.50
Aug. 13, 2024CFO14,100$150.38Sell$2,120,358.00
Aug. 13, 2024Director11,570$150.43Sell$1,740,475.10
Aug. 13, 2024Insider7,143$150.10Sell$1,072,164.30
Aug. 6, 2024Insider273$147.70Sell$40,322.10
Aug. 1, 2024Insider12,632$153.26Sell$1,935,980.32
July 16, 2024Director930$150.03Sell$139,527.90
July 16, 2024Insider900$150.04Sell$135,036.00
July 1, 2024Insider10,000$140.19Sell$1,401,900.00
May 29, 2024Director40,000$133.46Sell$5,338,400.00
May 17, 2024Director1,106$141.90Sell$156,941.40
May 15, 2024CFO15,000$140.24Sell$2,103,600.00
May 14, 2024Director12,500$135.63Sell$1,695,375.00
May 6, 2024Insider273$140.55Sell$38,370.15
April 15, 2024Insider19,818$133.36Sell$2,642,928.48
March 21, 2024Insider5,000$145.06Sell$725,300.00
March 14, 2024Director40,000$139.42Sell$5,576,800.00
March 14, 2024Insider75,000$139.38Sell$10,453,500.00
March 11, 2024Insider200$140.00Sell$28,000.00
March 11, 2024Director100$140.00Sell$14,000.00
March 8, 2024Insider1,800$140.03Sell$252,054.00
March 8, 2024Director1,700$140.05Sell$238,085.00
Feb. 29, 2024Insider273$135.51Sell$36,994.23
Feb. 27, 2024Director8,000$135.67Sell$1,085,360.00
Feb. 20, 2024Director15,000$132.47Sell$1,987,050.00
Feb. 13, 2024Insider1,114$132.96Sell$148,117.44
Feb. 13, 2024CEO2,832$133.02Sell$376,712.64
Feb. 13, 2024CFO1,352$132.85Sell$179,613.20
Feb. 8, 2024CEO2,274$134.15Sell$305,057.10
Feb. 8, 2024Insider1,328$135.41Sell$179,824.48
Feb. 8, 2024CFO980$134.21Sell$131,525.80
Feb. 6, 2024CFO1,280$142.19Sell$182,003.20
Feb. 6, 2024Insider456$141.96Sell$64,733.76
Feb. 6, 2024CEO3,040$142.18Sell$432,227.20
Jan. 31, 2024Insider1,457$140.79Sell$205,131.03
Jan. 31, 2024CEO2,707$140.69Sell$380,847.83
Jan. 31, 2024CFO1,283$140.72Sell$180,543.76
Jan. 22, 2024Insider10,000$139.86Sell$1,398,600.00
Jan. 8, 2024CEO105,835$132.44Sell$14,016,787.40
Jan. 2, 2024Director11,044$131.47Sell$1,451,954.68
Jan. 2, 2024Insider75,000$131.47Sell$9,860,250.00
Dec. 22, 2023Insider10,000$126.74Sell$1,267,400.00
Dec. 12, 2023Insider13,925$120.30Sell$1,675,177.50
Dec. 8, 2023Insider300$120.10Sell$36,030.00
Dec. 6, 2023Insider20,830$119.86Sell$2,496,683.80
Dec. 1, 2023Director5,000$116.77Sell$583,850.00
Nov. 29, 2023Insider2,331$113.57Sell$264,731.67
Nov. 27, 2023Insider10,919$112.27Sell$1,225,876.13
Oct. 2, 2023Insider1,437$112.68Sell$161,921.16
Sept. 12, 2023Director5,000$115.02Sell$575,100.00
First«1 of 6»Last
  • Insiders are both buying and selling Neurocrine Biosciences Inc stock.

  • The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Gary A Lyons, Darin Lippoldt, Haig P Bozigian, Dimitri E Grigoriadis, Christopher Flint Obrien, Matt Abernethy, Eiry Roberts, Eric Benevich, Timothy P Coughlin, Kyle Gano, Malcolm Lloyd-Smith, Julie Cooke, Ingrid Delaet, Richard F Pops, William H Rastetter, David W Boyer, W Thomas Mitchell, Stephen A Sherwin, Timothy Coughlin, Corinne H Nevinny, Jude Onyia, Dimitri Grigoriadis, Haig Bozigian, Dimitri E. Grigoriadis, Shalini Sharp, Leslie V. Norwalk, Gary A. Lyons, George J. Morrow, Haig P. Bozigian, and Neurocrine Biosciences Inc

  • The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 41 trades.

  • Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $98,873,670.68.

  • Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.

  • The most recent insider trade for Neurocrine Biosciences Inc was on Aug. 15, 2024.

  • The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.

  • The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.